Aldagen Inc.

Aldagen Receives CEO Cancer Gold StandardTM Accreditation.
Business Wire; 12/23/2009; 1051 words; CARY, N.C. -- Aldagen, Inc. has received CEO Cancer Gold Standard([TM]) accreditation...Cancer Center, Virtua Health and The Wistar Institute. About Aldagen, Inc. Aldagen is a biopharmaceutical company developing proprietary regenerative...

AVEO Files $86M IPO to Support New Phase III Kidney Cancer Trial.
BIOWORLD Today; 12/18/2009; 1290 words; ...antibiotic company Trius Therapeutics Inc., ophthalmology player Alimera Sciences Inc., cardiovascular company Anthera Pharmaceuticals Inc., stem cell developer Aldagen Inc., and diagnostic/specialty firm Prometheus Laboratories Inc. It may not...

Research and Markets Offers Report: Global Stem Cell and Advanced Technologies Market
Wireless News; 12/8/2009; 793 words; ...market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp...Companies Mentioned: - Advanced Cell Technology Inc - Aldagen - Angel Biotechnology - Angioblast Systems Inc - Aastrom Biosciences Inc - Athersys - Bioheart...

Research and Markets Adds Report: Global Stem Cell and Advanced Technologies Market
Wireless News; 12/7/2009; 792 words; ...market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp...Companies Mentioned: - Advanced Cell Technology Inc - Aldagen - Angel Biotechnology - Angioblast Systems Inc - Aastrom Biosciences Inc - Athersys - Bioheart...

Aldagen, not Talecris, will be IPO test case.(Triangle)
Business North Carolina; 12/1/2009; 923 words; ...will come if and when Durham-based Aldagen Inc. goes through with its $80.5...sometime after the first of the year. Aldagen is a money-losing company trying...partner of Pappas Ventures in Durham. Aldagen scrapped an plan to go public a year...